Max Healthcare Institute Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Competition Commission of India (CCI) has passed orders dated May 21, 2026 in favour of Max Healthcare's network hospitals, closing investigations into alleged abuse of dominant position under Section 4 of the Competition Act, 2002. This resolves a long-standing investigation that began in August 2018 when CCI directed the Director General to re-investigate pricing practices of hospitals in Delhi. The company's six network hospitals were among those investigated. CCI reviewed supplementary investigation reports, hospital objections, and submissions before rejecting the DG's findings and clearing all involved hospitals. The company received the orders on May 21, 2026 at 9.47 pm IST.
This is a positive development for Max Healthcare as the closure eliminates regulatory uncertainty and potential antitrust liability, removing a overhang that has been pending since 2018. The stock could see a relief rally as investors had been monitoring this case.